 Comparison continuous subcutaneous intravenous hydromorphone infusions management cancer pain safety efficacy subcutaneous intravenous infusion opioid analgesics randomised double-blind crossover trial inpatients patients severe cancer pain infusions hydromorphone order study double-blind use infusion pumps active subcutaneous infusion intravenous pump saline vice versa Serial measurements pain intensity pain relief mood sedation means visual analogue scales significant difference infusion routes Side-effects slight mean number morphine injections breakthrough pain routes SD intravenous vs subcutaneous Plasma hydromorphone concentrations infusion stable steady-state pharmacokinetics mean bioavailability subcutaneous infusion intravenous infusion simplicity technical advantages cost-effectiveness continuous subcutaneous opioid infusion wall trunk intravenous opioid infusion management severe cancer pain